Pravastatin induces cell cycle arrest and decreased production of VEGF and bFGF in multiple myeloma cell line

Abstract Multiple myeloma (MM) is a B cell bone marrow neoplasia characterized by inflammation with an intense secretion of growth factors that promote tumor growth, cell survival, migration and invasion. The aim of this study was to evaluate the effects of pravastatin, a drug used to reduce cholesterol, in a MM cell line.Cell cycle and viability were determinate by Trypan Blue and Propidium Iodide. IL6, VEGF, bFGF and TGFβ were quantified by ELISA and qRT-PCR including here de HMG CoA reductase. It was observed reduction of cell viability, increase of cells in G0/G1 phase of the cell cycle and reducing the factors VEGF and bFGF without influence on 3-Methyl-Glutaryl Coenzyme A reductase expression.The results demonstrated that pravastatin induces cell cycle arrest in G0/G1 and decreased production of growth factors in Multiple Myeloma cell line.

Bibliographic Details

Main Authors:	Trojan,P. J. J., Bohatch-Junior,M. S., Otuki,M. F., Souza-Fonseca-Guimarães,F., Svidnicki,P. V., Nogaroto,V., Fernandes,D., Krum,E. A., Favero,G. M.
Format:	Digital revista
Language:	English
Published:	Instituto Internacional de Ecologia 2016
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842016000100059
Tags:	Add Tag No Tags, Be the first to tag this record!